These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 101975)

  • 1. [Recurrence of pulmonary tuberculosis in Poland. 2. Risk factors].
    Szczuka I; Leowski J; Rudzińska H
    Pneumonol Pol; 1978 Aug; 46(8):565-76. PubMed ID: 101975
    [No Abstract]   [Full Text] [Related]  

  • 2. [Psychosocial risk factors in pulmonary tuberculosis and the phenomenon of drug resistance in its treatment].
    Pecyna MB
    Wiad Lek; 1988 Jan; 41(1):1-8. PubMed ID: 3136589
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical course and chemotherapy of hyperchronic destructive pulmonary tuberculosis].
    Mamolat AS; Bialik IB; Khutorskaia VD
    Probl Tuberk; 1985; (10):24-8. PubMed ID: 3934660
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Virulence of polyresistant strains of Mycobacterium tuberculosis].
    Drabkina RO; Klimenko MT
    Probl Tuberk; 1978 Nov; (11):70-5. PubMed ID: 103091
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relations between resistance and virulence of mycobacteria].
    Daddi G
    Arch Monaldi; 1972; 27(4):426-35. PubMed ID: 4217599
    [No Abstract]   [Full Text] [Related]  

  • 7. [A clinical study on the virulence of INH-resistant tubercle bacilli in the human body].
    Murata A
    Kekkaku; 1967 Aug; 42(8):309-11. PubMed ID: 4966678
    [No Abstract]   [Full Text] [Related]  

  • 8. [Resistance and virulence of mycobacteria. Clinical and experimental studies].
    Lucchesi M
    Ftiziologia; 1971; 20(4):401-4. PubMed ID: 5005707
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alcoholism and pulmonary tuberculosis].
    Khomenko AG; Rudoĭ NM; Utkin VV; Mikheeva LP
    Vestn Akad Med Nauk SSSR; 1989; (2):50-8. PubMed ID: 2496535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of patients with chronic destructive pulmonary tuberculosis in cases of mycobacterial resistance to rifampicin and isoniazid].
    Bialik IB; Klimenko MT
    Klin Med (Mosk); 1985 Dec; 63(12):42-7. PubMed ID: 3937942
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical aspects of secondary resistance in pulmonary tuberculosis].
    Gugić B
    Plucne Bolesti; 1985; 37(1-2):22-7. PubMed ID: 3934690
    [No Abstract]   [Full Text] [Related]  

  • 12. [Correlation of risk factors of pulmonary tuberculosis].
    Chodkowska M; Kuś L
    Pneumonol Pol; 1987 Jun; 55(6):270-7. PubMed ID: 3684730
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the infection of drug-resistant tubercle bacilli. 3. Experimental studies on the infection of INH highly-resistant tubercle bacilli].
    Osato T; Toyohara M; Aoki M; Hatori H
    Kekkaku; 1968 Nov; 43(11):473-9. PubMed ID: 4975533
    [No Abstract]   [Full Text] [Related]  

  • 14. [The environment of patients with severe pulmonary tuberculosis. Socioeconomic problems].
    Madey B; Dubaniewicz A
    Wiad Lek; 1987 Sep; 40(17):1153-6. PubMed ID: 3442010
    [No Abstract]   [Full Text] [Related]  

  • 15. [The clinical value of Mycobacterium tuberculosis with different biological properties].
    Vishnevskiĭ BI; Ivanova LA; Kolechko NG; Kochanova NK; Makovskaia GM
    Probl Tuberk; 1991; (4):51-4. PubMed ID: 1906617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative characteristics of disseminated pulmonary tuberculosis in patients isolating Mycobacterium tuberculosis with a high and low viability].
    Koretskaia NM; Iarygina IV
    Probl Tuberk Bolezn Legk; 2007; (2):17-20. PubMed ID: 17419328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Resistance of Mycobacterium tuberculosis in Ferrol, Spain. Associated factors].
    García Rodríguez JF; Mariño Callejo A; Lorenzo García MV; Rodríguez Mayo M; Domínguez Gómez D; Sesma Sánchez P
    Med Clin (Barc); 1999 Nov; 113(15):572-4. PubMed ID: 10605682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy with Mycobacterium vaccae and the treatment of tuberculosis.
    Stanford JL; Stanford CA
    Soc Appl Bacteriol Symp Ser; 1996; 25():81S-86S. PubMed ID: 8972123
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors affecting the outcome of treatment of pulmonary tuberculosis in sub-optimal conditions: an 18-month follow-up of 224 patients.
    Shennan DH; Westwater ML
    Cent Afr J Med; 1971 Jan; ():Suppl:1-10. PubMed ID: 4997533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.